A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Clinical trial NCT02038777 · COMPLETED

Trial details

NCT number: NCT02038777
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2014-03-25
Primary completion: 2021-02-12
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.